Evidence map›Paper›PMID 42817229›Full record

ReviewRenal failure2026

Microplastics and IgA nephropathy: a novel environmental hypothesis of immune dysregulation.

Joel Shah, William Wells-Gatnik, Biff F Palmer, Deborah J Clegg

Abstract readReview
In one paragraph

Review in Renal failure, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Joel ShahDepartment of Internal Medicine, Texas Tech University Health Sciences Center, El Paso, TX, USA.
William Wells-GatnikDepartment of Internal Medicine, Texas Tech University Health Sciences Center, El Paso, TX, USA.
Biff F PalmerDepartments of Education and Internal Medicine, Texas Tech University Health Sciences Center, El Paso, TX, USA.
Deborah J CleggDepartment of Internal Medicine, Vice President for Research, Texas Tech University Health Sciences Center, El Paso, TX, USA.ORCID 0000-0003-3506-4402

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IgA nephropathy (IgAN) is the most common glomerulonephritis worldwide, characterized by a 4-hit pathogenesis primarily driven by mucosal immune dysregulation in the gut-associated lymphoid tissue (GALT). However, the specific environmental triggers initiating this cascade remain elusive. We propose a novel hypothesis that chronic exposure to ubiquitous micro- and nano-plastics (MNPs) serves as a primary environmental catalyst for IgAN. Through a proposed 5-step cascade, we outline how ingested MNPs directly degrade intestinal tight junctions, precipitating a 'leaky gut' that permits the synergistic influx of plastics and commensal bacterial antigens into the GALT. Acting as a 'Trojan horse,' MNP-corona complexes evade immune detection but trigger chronic inflammation and B-cell dysregulation upon internalization by phagocytes. This persistent immune stimulation drives the aberrant production of galactose-deficient IgA1. Furthermore, we hypothesize that circulating MNPs co-deposit in the renal mesangium alongside immune complexes, acting as a dual generator of both systemic immune complexes and direct structural kidney injury. This potential gene-environment interaction is supported by the intersecting high prevalence of environmental MNPs and IgAN in Asia. Finally, we delineate future

Indexed as

Environmental ExposureGlomerulonephritis, IGAMicroplasticsAnimalsAntigen-Antibody ComplexGene-Environment InteractionHumansImmunoglobulin AAntigen-Antibody ComplexImmunoglobulin AMicroplasticsgalactose deficient IgA1 antibodiesIgA nephropathymicroplasticsnanoplastics

Identifiers

PMID42817229
PMCPMC13637761

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.